It is noted that there were no significant differences in CSF VILIP-1 levels among Alzheimer’s disease patients, mild cognitive-impaired individuals, and cognitively normal individuals who displayed amyloid-β positivity [190]. This evidence concerns the gene VSNL1 and Alzheimer disease.